Surfactant Application During Extracorporeal Membrane Oxygenation Improves Lung Volume and Pulmonary Mechanics in Children with Respiratory Failure

Overview

Journal Crit Care

Specialty Critical Care

Date 2005 Nov 11

PMID 16280067

Citations 6

Authors

Michael Hermon

Gudrun Burda

Christoph Male

Harald Boigner

Walter Ponhold

August Khoss

Wolfgang Strohmaier

Gerhard Trittenwein

Affiliations

Soon will be listed here.

Abstract

Introduction: This study was performed to determine whether surfactant application during extracorporeal membrane oxygenation (ECMO) improves lung volume, pulmonary mechanics, and chest radiographic findings in children with respiratory failure or after cardiac surgery.

Methods: This was a retrospective chart review study in a pediatric intensive care unit (PICU). Seven patients received surfactant before weaning from ECMO was started (group S). They were compared to six patients treated with ECMO who did not receive surfactant (group C). These control patients were matched based on age, weight, and underlying diagnosis. Demographic data, ventilator settings, tidal volume, compliance of respiratory system (calculated from tidal volume/(peak inspiratory pressure - positive end-expiratory pressure), and ECMO flow were extracted. Chest radiographs were scored by two blinded and independent radiologists. Changes over time were compared between groups by repeated-measures analysis of variance (time*group interaction). Values are given as percentages of baseline values.

Results: The groups did not differ with regard to demographic data, duration of ECMO, ventilator settings, PICU and hospital days. After application of surfactant, mean tidal volume almost doubled in group S (from 100% before to 186.2%; p = 0.0053). No change was found in group C (100% versus 98.7%). Mean compliance increased significantly (p = 0.0067) in group S (from 100% to 176.1%) compared to group C (100% versus 97.6%). Radiographic scores tended to decrease in group S within 48 h following surfactant application. ECMO flow tended to decrease in group S within 10 h following surfactant application but not in group C. Mortality was not affected by treatment.

Conclusion: Surfactant application may be of benefit in children with respiratory failure treated with ECMO, but these findings need confirmation from prospective studies.

Citing Articles

Surfactant therapy to facilitate weaning in paediatric patients dependent on extacorporeal membrane oxygenation.

Achanta N, Vujcikova J, Nichani S, Nichani S BMJ Case Rep. 2020; 13(11).

PMID: 33139367 PMC: 7607566. DOI: 10.1136/bcr-2020-237012.

Veno-venous ECMO as a platform to evaluate lung lavage and surfactant replacement therapy in an animal model of severe ARDS.

Qaqish R, Watanabe Y, Galasso M, Summers C, Ali A, Takahashi M Intensive Care Med Exp. 2020; 8(1):63.

PMID: 33108583 PMC: 7591687. DOI: 10.1186/s40635-020-00352-w.

Surfactant Administration During Pediatric Extracorporeal Membrane Oxygenation.

Shein S, Maul T, Li H, Kurland G ASAIO J. 2015; 61(6):682-7.

PMID: 26181713 PMC: 4631677. DOI: 10.1097/MAT.0000000000000266.

What's new in surfactant? A clinical view on recent developments in neonatology and paediatrics.

Been J, Zimmermann L Eur J Pediatr. 2007; 166(9):889-99.

PMID: 17516084 PMC: 7102086. DOI: 10.1007/s00431-007-0501-4.

Year in review 2005: Critical Care--respirology: mechanical ventilation, infection, monitoring, and education.

Haitsma J, Villar J, Slutsky A Crit Care. 2006; 10(3):217.

PMID: 16817943 PMC: 1550947. DOI: 10.1186/cc4959.

References

Bernard G, Artigas A, Brigham K, Carlet J, Falke K, Hudson L . The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994; 149(3 Pt 1):818-24. DOI: 10.1164/ajrccm.149.3.7509706. View

Garg M, Lew C, Ramos A, Platzker A, Keens T . Serial measurement of pulmonary mechanics assists in weaning from extracorporeal membrane oxygenation in neonates with respiratory failure. Chest. 1991; 100(3):770-4. DOI: 10.1378/chest.100.3.770. View

Koumbourlis A, MOTOYAMA E, Mutich R, Nakayama D, THOMPSON A . Lung mechanics during and after extracorporeal membrane oxygenation for meconium aspiration syndrome. Crit Care Med. 1992; 20(6):751-6. DOI: 10.1097/00003246-199206000-00009. View

Lotze A, Knight G, Martin G, Bulas D, HULL W, ODonnell R . Improved pulmonary outcome after exogenous surfactant therapy for respiratory failure in term infants requiring extracorporeal membrane oxygenation. J Pediatr. 1993; 122(2):261-8. DOI: 10.1016/s0022-3476(06)80131-9. View

Greenspan J, Antunes M, Holt W, McElwee D, Cullen J, Spitzer A . Pulmonary sequelae in infants treated with extracorporeal membrane oxygenation. Pediatr Pulmonol. 1997; 23(1):31-8. DOI: 10.1002/(sici)1099-0496(199701)23:1<31::aid-ppul4>3.0.co;2-s. View

Maksoud-Filho J, Diniz E, Ceccon M, Galvani A, Chamelian M, Pinho M . [Extracorporeal membrane oxygenation (ECMO) in a neonate with respiratory distress due to meconium aspiration syndrome: Effect of the administration of exogenous surfactant]. J Pediatr (Rio J). 2003; 77(3):243-8. DOI: 10.2223/jped.212. View

Kelly Jr R, Phillips J, Foglia R, Bjerke H, Barcliff L, Petrus L . Pulmonary edema and fluid mobilization as determinants of the duration of ECMO support. J Pediatr Surg. 1991; 26(9):1016-22. DOI: 10.1016/0022-3468(91)90665-g. View

Freezer N, Butt W, Sly P . Pulmonary mechanics and outcome of neonates on ECMO. Pediatr Pulmonol. 1991; 11(2):108-12. DOI: 10.1002/ppul.1950110206. View

Stillerman L, Gunn S, Hart J, ENGLE W . Effects of exogenous surfactant on neonates supported by extracorporeal membrane oxygenation. J Perinatol. 1997; 17(4):262-5. View

10.

Reiterer F, Zobel G, Urlesberger B, Maurer U, Riccabona M, Dacar D . Assessment of lung function in neonates during extracorporeal membrane oxygenation. Wien Klin Wochenschr. 1997; 109(6):192-6. View

11.

Moses D, Holm B, Spitale P, Liu M, ENHORNING G . Inhibition of pulmonary surfactant function by meconium. Am J Obstet Gynecol. 1991; 164(2):477-81. DOI: 10.1016/s0002-9378(11)80003-7. View

12.

Chou P, Blei E, Shen-Schwarz S, GONZALEZ-CRUSSI F, Reynolds M . Pulmonary changes following extracorporeal membrane oxygenation: autopsy study of 23 cases. Hum Pathol. 1993; 24(4):405-12. DOI: 10.1016/0046-8177(93)90089-y. View

13.

Steinhorn D . Termination of extracorporeal membrane oxygenation for cardiac support. Artif Organs. 1999; 23(11):1026-30. DOI: 10.1046/j.1525-1594.1999.06445.x. View

14.

Kugelman A, Saiki K, Platzker A, Garg M . Measurement of lung volumes and pulmonary mechanics during weaning of newborn infants with intractable respiratory failure from extracorporeal membrane oxygenation. Pediatr Pulmonol. 1995; 20(3):145-51. DOI: 10.1002/ppul.1950200304. View

15.

Green T, Moler F, Goodman D . Probability of survival after prolonged extracorporeal membrane oxygenation in pediatric patients with acute respiratory failure. Extracorporeal Life Support Organization. Crit Care Med. 1995; 23(6):1132-9. DOI: 10.1097/00003246-199506000-00021. View

16.

Struber M, Haverich A . Extracorporeal membrane oxygenation -- new developments. Thorac Cardiovasc Surg. 1999; 47 Suppl 2:304-6. DOI: 10.1055/s-2007-1012053. View

17.

Lotze A, Whitsett J, Kammerman L, Ritter M, Taylor G, Short B . Surfactant protein A concentrations in tracheal aspirate fluid from infants requiring extracorporeal membrane oxygenation. J Pediatr. 1990; 116(3):435-40. DOI: 10.1016/s0022-3476(05)82839-2. View

18.

Hallman M, Kankaanpaa K . Evidence of surfactant deficiency in persistence of the fetal circulation. Eur J Pediatr. 1980; 134(2):129-34. DOI: 10.1007/BF01846031. View

19.

Edwards D, Hilton S, Merritt T, Hallman M, Mannino F, Boynton B . Respiratory distress syndrome treated with human surfactant: radiographic findings. Radiology. 1985; 157(2):329-34. DOI: 10.1148/radiology.157.2.3840268. View